• 1. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

Introduction to 9,10-Dichloro-2,6-bis(bromomethyl)anthracene (CAS No. 887354-43-0)

9,10-Dichloro-2,6-bis(bromomethyl)anthracene, with the chemical formula C??H?Br?Cl?, is a significant compound in the field of organic synthesis and pharmaceutical research. This heterocyclic aromatic molecule belongs to the anthracene family, characterized by its tricyclic structure composed of three benzene rings fused together. The presence of multiple reactive sites, including chlorine and bromomethyl substituents, makes it a versatile intermediate in the development of various chemical entities.

The compound's unique structural features have garnered considerable attention in recent years due to its potential applications in medicinal chemistry and materials science. Specifically, the chloro and bromomethyl groups provide excellent handles for further functionalization through nucleophilic substitution reactions, enabling the synthesis of more complex molecules. This reactivity has been exploited in the design of novel therapeutic agents and advanced materials.

In the realm of pharmaceutical research, 9,10-Dichloro-2,6-bis(bromomethyl)anthracene has been explored as a precursor for developing small-molecule inhibitors targeting various biological pathways. Recent studies have highlighted its utility in generating derivatives with potent anticancer properties. For instance, researchers have demonstrated that by introducing specific nitrogen-containing heterocycles or other bioactive moieties into the anthracene core, compounds with enhanced cytotoxicity against tumor cell lines can be obtained.

One notable application of this compound is in the synthesis of photosensitizers for photodynamic therapy (PDT). Anthracene derivatives are known for their ability to absorb light in the near-infrared region, which is advantageous for clinical applications due to reduced tissue autofluorescence. The bromomethyl groups on 9,10-Dichloro-2,6-bis(bromomethyl)anthracene allow for the introduction of photosensitizer moieties such as porphyrins or phthalocyanines, leading to improved efficacy in cancer treatment.

The compound's reactivity also extends to materials science, where it serves as a building block for organic semiconductors and optoelectronic materials. Anthracene-based polymers and small molecules exhibit excellent charge transport properties, making them suitable for use in organic light-emitting diodes (OLEDs), field-effect transistors (OFETs), and photovoltaic devices. The chlorine and bromomethyl substituents facilitate further modifications to optimize these properties for specific applications.

Recent advancements in synthetic methodologies have further enhanced the utility of 9,10-Dichloro-2,6-bis(bromomethyl)anthracene. For example, transition-metal-catalyzed cross-coupling reactions have enabled the introduction of aryl or heteroaryl groups at various positions on the anthracene core. These modifications have led to a new generation of compounds with tailored electronic and photophysical properties.

In summary, 9,10-Dichloro-2,6-bis(bromomethyl)anthracene (CAS No. 887354-43-0) is a multifaceted compound with broad applications in pharmaceuticals and materials science. Its unique structural features and reactivity make it an invaluable intermediate for designing novel therapeutic agents and advanced materials. As research continues to uncover new synthetic strategies and applications, this compound is poised to play an even greater role in future scientific endeavors.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)